Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Second-line targeted therapies after nivolumab-ipilimumab failure in metastatic renal cell carcinoma

Second-line targeted therapies after nivolumab-ipilimumab failure in metastatic renal cell carcinoma http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png European Journal of Cancer Unpaywall

Second-line targeted therapies after nivolumab-ipilimumab failure in metastatic renal cell carcinoma

Download PDF
Loading next page...
 
/lp/unpaywall/second-line-targeted-therapies-after-nivolumab-ipilimumab-failure-in-KPvXfqcYpX

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
Unpaywall
ISSN
0959-8049
DOI
10.1016/j.ejca.2018.11.031
Publisher site
See Article on Publisher Site

Abstract

Journal

European Journal of Cancer – Unpaywall

Published: Feb 1, 2019

There are no references for this article.